This Brain Cancer Diagnostics market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Brain Cancer Diagnostics market.
Brain cancers are the extracellular growth in the brain that includes primary brain tumors, and secondary brain tumors. Primary brain tumors start in the brain and do not spread to other parts of the body while the secondary tumors or metastases are those, which are caused by cancers that began in another part of the body. Brain tumors may be categorized into 40 major types, which are grouped into two major groups such as benign and slow growing with less possibility to spread and the other type is the malignant and cancerous that is more likely to spread. There are some causes, which results in brain cancer and are more common in people with certain gene factor or hereditary conditions. Brain cancer can also be caused due to the exposure of very high doses of radiation to head. Brain cancer is most commonly diagnosed through MRI. Other prevalent methods include angiograms, CT scans, diffusion tensor imaging, fMRI, etc. Technological evolution coupled with accelerated demand for faster diagnosis are factors pushing R&D in the brain cancer diagnostics market.
Brain Cancer Diagnostics Market: Drivers & Restraints
Revenue growth in the brain cancer diagnostics market is expected to be fuelled by factors such as technological advancements from conventional techniques. This has helped improve speed as well as the accuracy of the diagnostic machines, yielding better results, which could finally make way for earlier adoption of treatments. Significant increase in brain cancer prevalence globally is expected to underpin market growth in near future. One of the major contribution factors is the rise in a number of cigarette smokers and other various environmental toxins, which causes brain cancer. Around 78,000 new cases of primary brain tumor are expected to be diagnosed this year; 25,000 of them are primary malignant and 53,000 non-malignant brain cancers.
Primary restraints include rising cost of diagnosis, low awareness levels and reduced accessibility to the same. In this regard, the rates of diagnosis are much higher in developed markets than in low-income countries.
Brain cancer diagnostics Market: Overview
Brain cancer diagnostics market is expected to expand at healthy growth rates across regions.In the U.S. alone the American Brain Tumor Association has predicted that nearly 78,000 new cases of primary brain tumors are expected to be diagnosed this year. Malignant brain tumors are the most common cause of cancer-related mortality in patients aged 15-39 years. It is also one of the most common cancers affecting 15-19-year-olds. The markets in European region too are expected to witness rising number of diagnosed cases given a cross-sectional aging in population levels. The diagnosis of meningioma followed by glioma and glioblastoma are expected to witness acceleration in the U.S. and EU5 countries
Brain Cancer Diagnostics Market: Region-wise Outlook
Depending on the geographic region, Brain cancer diagnostics market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa.
North America is expected to account for the largest market by revenue generation from diagnosis of brain cancers due to etiological trends and lifestyle oriented problems apart from genetic issues. Eastern and Western Europe are expected to reflect accelerated diagnosis rates owing to the availability of reimbursement facilities. With the rise in standards of health care services in Asia Pacific countries is expected to favor the market for brain cancer diagnostics. The increase in healthcare expenditure stemming from government budgets could raise diagnostic infrastructure standards in Asia Pacific countries. Amongst the Asian countries, China, India, Australia and New Zealand and South Korea is expected to be more promising because of rising per capita spending on healthcare as well as large developments in healthcare infrastructure.
Brain Cancer Diagnostics Market: Key Players
GE Healthcare, Hologic, Inc., NantOmics, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Inc., are some of the participating global players in brain cancer diagnostics market.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, braincancer type, and end-users.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Argentina, Brazil, Mexico and Rest of Latin America)
- Western Europe (Germany, France, Italy, U.K, Spain, Benelux, Rest of Western Europe)
- Eastern Europe (Poland, Russia, Rest of Western Europe)
- Asia Pacific (China, ASEAN, Australia & New Zealand, Rest of APEJ)
- Middle Eastand Africa (GCC, S. Africa)
The report is a compilation of first-hand information, qualitative, and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Unique Requirements? Customize this Report
- Customize by Region, Country, Application, Product, & other segments
- Integrate our Insights with your Existing Data
- Determine the scope of the study to suit your requirements
Let FMI Help You!
- Gain Insights on Key Brain Cancer Diagnostics Market Impacting Forces
- Know the Winning Strategies of Market Leaders
- Get Deep-Dive Analysis on Each Segment
- Identify the Sources that will Drive Top-Line Revenue
Brain Cancer Diagnostics Market: Segmentation
Brain cancer diagnostics market is classified on the basis of test type, brain cancer type, and end-user.
Based on test type, the brain cancer diagnostics market is segmented into the following:
- Magnetic Resonance Spectroscopy
- PET Scan
- Single Photon Emission CT Scan (SPECT)
- Spinal Tap
- Magnetic Resonance Imaging (MRI)
Based on Brain Cancer Type, the Brain cancer diagnostics Market is segmented into the following:
- Acoustic neuroma
- Choroid plexus papilloma
- Glioblastoma multiforme
- Others (mixed, optic nerve and brainstem gliomas, oligodendroglioma, pineal tumors, pituitary adenomas, primitive neuroectodermal tumors, schwannomas, vascular tumors)
Based on End-User, the brain cancer diagnostics market is segmented into the following:
- Cancer Diagnostic Center
- Cancer Research Institutes
Based on geography, the Brain cancer diagnostics Market is segmented into following:
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France,Rest of Western Europe)
- Eastern Europe (Russia)
- Asia-Pacific(China, India, ASEAN, Australia & New Zealand)
- Middle Eastand Africa (GCC, S. Africa)
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions
Why choose FMI?
- With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
- Market Reports researched and peer reviewed by industry experts from across the globe
- We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
- In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
- Primary research includes mandatory field interviews with stakeholders involved
- Customizing reports according to client specification is also our forte
What will you discover from Brain Cancer Diagnostics Market report?
- The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
- An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
- Extensive database and key dynamics elevating the market with varied verticals associated
- Underlying Brain Cancer Diagnostics Market forces that are compelling consumers or businesses to purchase the product
- How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Brain Cancer Diagnostics Market
- What will be environment and regulatory impacts on the market over the next decade
Which framework has been used to develop the Brain Cancer Diagnostics Market report?
- Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
- Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
- Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)